EX-25.1 4 ex25-1.htm EX. 25.1 STATEMENT OF ELIGIBILITY OF TRUSTEE UNDER THE SENIOR INDENTURE ON FORM T-1 ex25-1.htm


Exhibit 25.1
 
= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
 
FORM T-1
 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
 
STATEMENT OF ELIGIBILITY
 
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
 
CORPORATION DESIGNATED TO ACT AS TRUSTEE
 
CHECK IF AN APPLICATION TO DETERMINE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2)           |__|
___________________________
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
 
(Exact name of trustee as specified in its charter)
 
 
(State of incorporation
if not a U.S. national bank)
95-3571558
(I.R.S. employer
identification no.)
700 South Flower Street
Suite 500
Los Angeles, California
(Address of principal executive offices)
 
 
90017
(Zip code)
Evelyn T. Furukawa
 
700 South Flower Street, Suite 500
 
Los Angeles, California 90017
 
213.630.6463
 
(Name, address and telephone number of agent for service)
 

 
Marathon Oil Corporation
 
(Exact name of obligor as specified in its charter)
 
Delaware
 (State or other jurisdiction of
incorporation or organization)
25-0996816
 (I.R.S. employer
identification no.)
 
5555 San Felipe Road
Houston, Texas
(Address of principal executive offices)
 
 
77056-2723
(Zip Code)
_________________
 



Senior Debt Securities
(Title of the Indenture Securities)







1.           General information.  Furnish the following information as to the trustee:
 
 
(a)
Name and address of each examining or supervising authority to which it is subject.
 
Name
Address
Comptroller of the Currency
United States Department of the Treasury
 
 
 
Washington, D.C. 20219
Federal Reserve Bank
San Francisco, California 94105
 
Federal Deposit Insurance Corporation
 
Washington, D.C. 20429
 
 (b)
Whether it is authorized to exercise corporate trust powers.
 
Yes.
 
 
 
2.
Affiliations with Obligor.
 
If the obligor is an affiliate of the trustee, describe each such affiliation.
 
None.
 
3-15.           Not applicable.
 
16.
List of Exhibits.
 
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the "Act") and 17 C.F.R. 229.10(d).
 
 
1.
A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A. (Exhibit 1 to Form T-1 filed as Exhibit 25.1 to the  Registration Statement on Form S-3 File No. 333-121948 and Exhibit 1 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-152875).
 

 
 
2.
A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-121948).
 
 
3.
A copy of the authorization of the trustee to exercise corporate trust powers. (Exhibit 3 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-152875).
 
 
4.
A copy of the existing by-laws of the trustee. (Exhibit 4 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-152875).
 
 
6.
The consent of the trustee required by Section 321(b) of the Act.
 
 
7.
A copy of the latest report of condition of the trustee published pursuant to law or to the requirements of its supervising or examining authority.
 
SIGNATURE
 
Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of Houston, and State of Texas, on the 16th day of July 2010.
 
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
 
 
By:  __/s/ Julie Hoffman-Ramos
 
Name: Julie Hoffman-Ramos
Title:   Senior Associate
                                       
 

 
 
 


 

 
CONSENT OF THE TRUSTEE
 

 
Pursuant to the requirements of Section 321 (b) of the Trust Indenture Act of 1939, and in connection with the proposed issue of Marathon Oil Corporation Debt Securities, The Bank of New York Mellon Trust Company, N.A. hereby consents that reports of examinations by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon request therefore.


THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.


By:_/s/ Julie Hoffman-Ramos
Julie Hoffman-Ramos
Senior Associate




Houston, Texas
July 16, 2010

 
 
 
 

REPORT OF CONDITION
 
[Missing Graphic Reference]
Consolidating domestic subsidiaries of
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, NA
in the state of CA at close of business on March 31, 2010
 
published in response to call made by (Enter additional information below)
 
Statement of Resources and Liabilities
             
   
Dollar Amounts
in Thousands
 
ASSETS
           
Cash and balances due from depository institutions:
           
Noninterest-bearing balances and currency and coin
          1,504  
Interest-bearing balances
          288  
Securities:
             
Held-to-maturity securities
          12  
Available-for-sale securities
          581,259  
Federal funds sold and securities purchased under agreements to resell:
             
Federal funds sold
          113,000  
Securities purchased under agreements to resell
          0  
Loans and lease financing receivables:
             
Loans and leases held for sale
          0  
Loans and leases, net of unearned income
    0          
LESS: Allowance for loan and lease losses
    0          
Loans and leases, net of unearned income and allowance
            0  
Trading Assets
            0  
Premises and fixed assets (including capitalized leases)
            10,486  
Other real estate owned
            0  
Investments in unconsolidated subsidiaries and associated companies
            2  
 Direct and indirect investments in real estate ventures
            0  
Intangible assets:
               
Goodwill
            856,313  
Other intangible assets
            237,642  
Other assets
            166,465  
Total assets
            1,966,971  
 
[Missing Graphic Reference]
REPORT OF CONDITION (Continued)
 
LIABILITIES
 
             
   
Dollar Amounts
in Thousands
 
Deposits:
     
In domestic offices
          533  
Noninterest- bearing
    533          
Interest-bearing
    0          
Federal funds purchased and securities sold under agreements to repurchase:
               
Federal funds purchased
            0  
Securities sold under agreements to repurchase
            0  
Trading liabilities
            0  
Other borrowed money (includes mortgage indebtedness and obligations under capitalized leases)
            268,691  
Subordinated notes and debentures
            0  
Other liabilities
            210,010  
Total liabilities
            479,234  
                 
EQUITY CAPITAL
Bank Equity Capital
               
                 
Perpetual preferred stock and related surplus
            0  
Common stock
            1,000  
Surplus (exclude all surplus related to preferred stock)
            1,121,520  
Retained earnings
            364,077  
Accumulated other comprehensive income
            1,140  
Other equity capital components
            0  
Total bank equity capital
            1,487,737  
Noncontrolling (minority) interest in consolidated subsidiaries
            0  
Total equity capital
            1,487,737  
Total liabilities and equity capital
            1,966,971  
 
     
We, the undersigned directors, attest to the
correctness of this statement of resources and liabilities.
We declare that it has been examined by us, and to the
best of our knowledge and belief has been
prepared in conformance with the instructions
and is true and correct.
  
 
I, Karen Bayz, Chief Financial Officer /s/ Karen Bayz
  
(Name, Title)
  
of the above named bank do hereby declare
that this Report of Condition is true and
correct to the best of my knowledge and belief.
 
             
Director #1
  
Troy Kilpatrick, President
  
/s/ Troy Kilpatrick
  
 
       
Director #2
  
Frank Sulzberger, MD
  
/s/ Frank Sulzberger
  
 
       
Director #3
  
William Lindelof, MD
  
/s/ William Lindelof